The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Recruiting · NCT06796504 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Recruiting | Not applicable | 2026-09-02 | NCT06796504 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SetPoint Medical Corporation | 4 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins School of Medicine | Baltimore | United States | 21 |
| Medical College of Wisconsin | Milwaukee | United States | 483 |
| Minnesota Center for Multiple Sclerosis | Plymouth | United States | 1 |
| Shepherd Center | Atlanta | United States | 10 |
| The University of Texas at Austin | Austin | United States | 23 |
| The University of Texas Health Science Center at Houston | Houston | United States | 207 |
| University of California Irvine Center for Clinical Research | Irvine | United States | 1 |
| UW Medicine Multiple Sclerosis Center-Northwest | Seattle | United States | 1 |
| West Virginia University | Morgantown | United States | 87 |